On the stock market since 2022, it operates in the everyday-essentials business. It has 600 employees. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
An average decline of 9% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
The stock trades 33% below its peak. The market has trimmed its expectations for the company.
Sales run at $176.5M a year. A small number, but proof the product has real buyers.
A loss of $14.9M against $176.5M in annual sales. And on top of that, sales fell from the year before.
At the current pace of spending, the cash lasts less than a year. After that, the company needs to find new money.
On our five-subject report card, AFRIW sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: AFRIW is a high-risk stock — not yet profitable, and its future rides on its product catching on.